• A study of irinotecan and a drug combination for patients with gastric cancer or gastroesophageal junction cancer undergoing surgery.

    Recruiting

    1 1 1 1
    Investigated Diseases:
    The Netherlands
  • A study to evaluate the effect of rimegepant in patients with migraine and obesity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria
  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Recruiting

    2 1 1
    Italy The Netherlands Spain
  • A study to evaluate the effectiveness and safety of Usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • A study to evaluate the effectiveness of tenecteplase in patients with acute ischemic stroke who are more than 4.5 hours after their last known well time.

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Greece Hungary Norway Romania Spain
  • A study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack

    Recruiting

    3 1 1
    Denmark
  • A study of pumitamig and a drug combination versus nivolumab and a drug combination for patients with untreated advanced or metastatic stomach or esophageal cancer

    Recruiting

    4 1 1 1
    France Germany Italy Poland Romania Spain
  • Study of the use of tasadenoturev for children and young adults with recurrent or resistant high-grade brain tumors

    Recruiting

    2 1 1
    The Netherlands Spain
  • A study to evaluate the safety and effectiveness of inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +4
  • A study to evaluate the effectiveness of epcoritamab in patients with Waldenström’s macroglobulinemia that has returned or has not responded to previous treatments.

    Recruiting

    1 1 1
    Investigated Drugs:
    Belgium Denmark The Netherlands

powered by